Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates

Area of Science:

• Biochemistry
• Neuroscience
• Computational Biology

Background:

• Amyloids, or fibrillar assemblies of polypeptide chains, are implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's.
• The precise molecular mechanisms driving the formation of toxic amyloid species remain largely unknown.
• While pathogenic amyloids cause disease, functional amyloid-like aggregates also exist in various organisms, with their self-assembly mechanisms poorly understood.

Purpose of the Study:

• To review atomistic and coarse-grained simulation studies on amyloid peptides across different aggregation states (monomeric, oligomeric, fibrillar).
• To highlight the challenges in characterizing the conformational space and aggregation of disordered polypeptides at atomic resolution.
• To discuss discrepancies between simulation results and experimental data and propose future simulation-based research directions.

Main Methods:

• Review of atomistic simulations.
• Review of coarse-grained simulations.
• Analysis of simulation studies focusing on amyloid peptide aggregation.

Main Results:

• Simulation studies provide insights into the conformational space of disordered polypeptides and their aggregation pathways.
• Challenges exist in achieving atomic-level detail and comparing simulation outputs with experimental findings.
• Understanding the differences between functional and pathogenic amyloid self-assembly requires further investigation.

Conclusions:

• Simulation studies are crucial for elucidating the molecular mechanisms of amyloid formation in neurodegenerative diseases.
• Addressing the challenges in simulation accuracy and experimental validation is key to advancing research.
• Future simulation-based investigations are proposed to deepen our understanding of disease-associated amyloid aggregation.